Global Recombinant Hormone Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Recombinant hormones are hormones that are manufactured in a laboratory using recombinant technology for therapeutic purposes. The endocrine system in the human body consists of glands (pituitary, thyroid, parathyroid, adrenal, pancreas, etc.) that produce hormones that regulate metabolism, growth and development, reproduction, sexual function, tissue function and other functions. If hormone levels are too high or too low, there is a problem with the endocrine system.
The global market for Recombinant Hormone is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Recombinant Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Recombinant Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Recombinant Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Recombinant Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Recombinant Hormone players cover Eli Lilly and Company, Ferring Pharmaceuticals, Merck, Pfizer and Novo Nordisk, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Recombinant Hormone market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Recombinant Hormone market, with both quantitative and qualitative data, to help readers understand how the Recombinant Hormone market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Recombinant Hormone market and forecasts the market size by Type (Growth Hormone, Insulin and Follicle-stimulating Hormone), by Application (Hospital, Clinic and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Recombinant Hormone, Research Methodology, etc.
Chapter 2: Executive Summary, global Recombinant Hormone market size (sales and revenue) and CAGR, Recombinant Hormone market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Recombinant Hormone sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Recombinant Hormone sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Recombinant Hormone market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Eli Lilly and Company, Ferring Pharmaceuticals, Merck, Pfizer, Novo Nordisk, Novartis AG, Ipsen, LG Chem and Teva Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Recombinant hormones are hormones that are manufactured in a laboratory using recombinant technology for therapeutic purposes. The endocrine system in the human body consists of glands (pituitary, thyroid, parathyroid, adrenal, pancreas, etc.) that produce hormones that regulate metabolism, growth and development, reproduction, sexual function, tissue function and other functions. If hormone levels are too high or too low, there is a problem with the endocrine system.
The global market for Recombinant Hormone is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Recombinant Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Recombinant Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Recombinant Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Recombinant Hormone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Recombinant Hormone players cover Eli Lilly and Company, Ferring Pharmaceuticals, Merck, Pfizer and Novo Nordisk, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Recombinant Hormone market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Recombinant Hormone market, with both quantitative and qualitative data, to help readers understand how the Recombinant Hormone market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Recombinant Hormone market and forecasts the market size by Type (Growth Hormone, Insulin and Follicle-stimulating Hormone), by Application (Hospital, Clinic and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Growth Hormone
- Insulin
- Follicle-stimulating Hormone
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly and Company
- Ferring Pharmaceuticals
- Merck
- Pfizer
- Novo Nordisk
- Novartis AG
- Ipsen
- LG Chem
- Teva Pharmaceutical
- Scripps Laboratories
Chapter 1: Scope of Recombinant Hormone, Research Methodology, etc.
Chapter 2: Executive Summary, global Recombinant Hormone market size (sales and revenue) and CAGR, Recombinant Hormone market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Recombinant Hormone sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Recombinant Hormone sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Recombinant Hormone market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Eli Lilly and Company, Ferring Pharmaceuticals, Merck, Pfizer, Novo Nordisk, Novartis AG, Ipsen, LG Chem and Teva Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Hormone Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Recombinant Hormone by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Recombinant Hormone by Country/Region, 2017, 2022 & 2028
2.2 Recombinant Hormone Segment by Type
2.2.1 Growth Hormone
2.2.2 Insulin
2.2.3 Follicle-stimulating Hormone
2.2.4 Others
2.3 Recombinant Hormone Sales by Type
2.3.1 Global Recombinant Hormone Sales Market Share by Type (2017-2022)
2.3.2 Global Recombinant Hormone Revenue and Market Share by Type (2017-2022)
2.3.3 Global Recombinant Hormone Sale Price by Type (2017-2022)
2.4 Recombinant Hormone Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Recombinant Hormone Sales by Application
2.5.1 Global Recombinant Hormone Sale Market Share by Application (2017-2022)
2.5.2 Global Recombinant Hormone Revenue and Market Share by Application (2017-2022)
2.5.3 Global Recombinant Hormone Sale Price by Application (2017-2022)
3 GLOBAL RECOMBINANT HORMONE BY COMPANY
3.1 Global Recombinant Hormone Breakdown Data by Company
3.1.1 Global Recombinant Hormone Annual Sales by Company (2020-2022)
3.1.2 Global Recombinant Hormone Sales Market Share by Company (2020-2022)
3.2 Global Recombinant Hormone Annual Revenue by Company (2020-2022)
3.2.1 Global Recombinant Hormone Revenue by Company (2020-2022)
3.2.2 Global Recombinant Hormone Revenue Market Share by Company (2020-2022)
3.3 Global Recombinant Hormone Sale Price by Company
3.4 Key Manufacturers Recombinant Hormone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Hormone Product Location Distribution
3.4.2 Players Recombinant Hormone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT HORMONE BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Hormone Market Size by Geographic Region (2017-2022)
4.1.1 Global Recombinant Hormone Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Recombinant Hormone Annual Revenue by Geographic Region
4.2 World Historic Recombinant Hormone Market Size by Country/Region (2017-2022)
4.2.1 Global Recombinant Hormone Annual Sales by Country/Region (2017-2022)
4.2.2 Global Recombinant Hormone Annual Revenue by Country/Region
4.3 Americas Recombinant Hormone Sales Growth
4.4 APAC Recombinant Hormone Sales Growth
4.5 Europe Recombinant Hormone Sales Growth
4.6 Middle East & Africa Recombinant Hormone Sales Growth
5 AMERICAS
5.1 Americas Recombinant Hormone Sales by Country
5.1.1 Americas Recombinant Hormone Sales by Country (2017-2022)
5.1.2 Americas Recombinant Hormone Revenue by Country (2017-2022)
5.2 Americas Recombinant Hormone Sales by Type
5.3 Americas Recombinant Hormone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Hormone Sales by Region
6.1.1 APAC Recombinant Hormone Sales by Region (2017-2022)
6.1.2 APAC Recombinant Hormone Revenue by Region (2017-2022)
6.2 APAC Recombinant Hormone Sales by Type
6.3 APAC Recombinant Hormone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Hormone by Country
7.1.1 Europe Recombinant Hormone Sales by Country (2017-2022)
7.1.2 Europe Recombinant Hormone Revenue by Country (2017-2022)
7.2 Europe Recombinant Hormone Sales by Type
7.3 Europe Recombinant Hormone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Hormone by Country
8.1.1 Middle East & Africa Recombinant Hormone Sales by Country (2017-2022)
8.1.2 Middle East & Africa Recombinant Hormone Revenue by Country (2017-2022)
8.2 Middle East & Africa Recombinant Hormone Sales by Type
8.3 Middle East & Africa Recombinant Hormone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Hormone
10.3 Manufacturing Process Analysis of Recombinant Hormone
10.4 Industry Chain Structure of Recombinant Hormone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Hormone Distributors
11.3 Recombinant Hormone Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT HORMONE BY GEOGRAPHIC REGION
12.1 Global Recombinant Hormone Market Size Forecast by Region
12.1.1 Global Recombinant Hormone Forecast by Region (2023-2028)
12.1.2 Global Recombinant Hormone Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Hormone Forecast by Type
12.7 Global Recombinant Hormone Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly and Company
13.1.1 Eli Lilly and Company Company Information
13.1.2 Eli Lilly and Company Recombinant Hormone Product Offered
13.1.3 Eli Lilly and Company Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly and Company Main Business Overview
13.1.5 Eli Lilly and Company Latest Developments
13.2 Ferring Pharmaceuticals
13.2.1 Ferring Pharmaceuticals Company Information
13.2.2 Ferring Pharmaceuticals Recombinant Hormone Product Offered
13.2.3 Ferring Pharmaceuticals Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Ferring Pharmaceuticals Main Business Overview
13.2.5 Ferring Pharmaceuticals Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Recombinant Hormone Product Offered
13.3.3 Merck Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Recombinant Hormone Product Offered
13.4.3 Pfizer Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Novo Nordisk
13.5.1 Novo Nordisk Company Information
13.5.2 Novo Nordisk Recombinant Hormone Product Offered
13.5.3 Novo Nordisk Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novo Nordisk Main Business Overview
13.5.5 Novo Nordisk Latest Developments
13.6 Novartis AG
13.6.1 Novartis AG Company Information
13.6.2 Novartis AG Recombinant Hormone Product Offered
13.6.3 Novartis AG Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis AG Main Business Overview
13.6.5 Novartis AG Latest Developments
13.7 Ipsen
13.7.1 Ipsen Company Information
13.7.2 Ipsen Recombinant Hormone Product Offered
13.7.3 Ipsen Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Ipsen Main Business Overview
13.7.5 Ipsen Latest Developments
13.8 LG Chem
13.8.1 LG Chem Company Information
13.8.2 LG Chem Recombinant Hormone Product Offered
13.8.3 LG Chem Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 LG Chem Main Business Overview
13.8.5 LG Chem Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Recombinant Hormone Product Offered
13.9.3 Teva Pharmaceutical Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Scripps Laboratories
13.10.1 Scripps Laboratories Company Information
13.10.2 Scripps Laboratories Recombinant Hormone Product Offered
13.10.3 Scripps Laboratories Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Scripps Laboratories Main Business Overview
13.10.5 Scripps Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Hormone Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Recombinant Hormone by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Recombinant Hormone by Country/Region, 2017, 2022 & 2028
2.2 Recombinant Hormone Segment by Type
2.2.1 Growth Hormone
2.2.2 Insulin
2.2.3 Follicle-stimulating Hormone
2.2.4 Others
2.3 Recombinant Hormone Sales by Type
2.3.1 Global Recombinant Hormone Sales Market Share by Type (2017-2022)
2.3.2 Global Recombinant Hormone Revenue and Market Share by Type (2017-2022)
2.3.3 Global Recombinant Hormone Sale Price by Type (2017-2022)
2.4 Recombinant Hormone Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Recombinant Hormone Sales by Application
2.5.1 Global Recombinant Hormone Sale Market Share by Application (2017-2022)
2.5.2 Global Recombinant Hormone Revenue and Market Share by Application (2017-2022)
2.5.3 Global Recombinant Hormone Sale Price by Application (2017-2022)
3 GLOBAL RECOMBINANT HORMONE BY COMPANY
3.1 Global Recombinant Hormone Breakdown Data by Company
3.1.1 Global Recombinant Hormone Annual Sales by Company (2020-2022)
3.1.2 Global Recombinant Hormone Sales Market Share by Company (2020-2022)
3.2 Global Recombinant Hormone Annual Revenue by Company (2020-2022)
3.2.1 Global Recombinant Hormone Revenue by Company (2020-2022)
3.2.2 Global Recombinant Hormone Revenue Market Share by Company (2020-2022)
3.3 Global Recombinant Hormone Sale Price by Company
3.4 Key Manufacturers Recombinant Hormone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Hormone Product Location Distribution
3.4.2 Players Recombinant Hormone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT HORMONE BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Hormone Market Size by Geographic Region (2017-2022)
4.1.1 Global Recombinant Hormone Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Recombinant Hormone Annual Revenue by Geographic Region
4.2 World Historic Recombinant Hormone Market Size by Country/Region (2017-2022)
4.2.1 Global Recombinant Hormone Annual Sales by Country/Region (2017-2022)
4.2.2 Global Recombinant Hormone Annual Revenue by Country/Region
4.3 Americas Recombinant Hormone Sales Growth
4.4 APAC Recombinant Hormone Sales Growth
4.5 Europe Recombinant Hormone Sales Growth
4.6 Middle East & Africa Recombinant Hormone Sales Growth
5 AMERICAS
5.1 Americas Recombinant Hormone Sales by Country
5.1.1 Americas Recombinant Hormone Sales by Country (2017-2022)
5.1.2 Americas Recombinant Hormone Revenue by Country (2017-2022)
5.2 Americas Recombinant Hormone Sales by Type
5.3 Americas Recombinant Hormone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Hormone Sales by Region
6.1.1 APAC Recombinant Hormone Sales by Region (2017-2022)
6.1.2 APAC Recombinant Hormone Revenue by Region (2017-2022)
6.2 APAC Recombinant Hormone Sales by Type
6.3 APAC Recombinant Hormone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Hormone by Country
7.1.1 Europe Recombinant Hormone Sales by Country (2017-2022)
7.1.2 Europe Recombinant Hormone Revenue by Country (2017-2022)
7.2 Europe Recombinant Hormone Sales by Type
7.3 Europe Recombinant Hormone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Hormone by Country
8.1.1 Middle East & Africa Recombinant Hormone Sales by Country (2017-2022)
8.1.2 Middle East & Africa Recombinant Hormone Revenue by Country (2017-2022)
8.2 Middle East & Africa Recombinant Hormone Sales by Type
8.3 Middle East & Africa Recombinant Hormone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Hormone
10.3 Manufacturing Process Analysis of Recombinant Hormone
10.4 Industry Chain Structure of Recombinant Hormone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Hormone Distributors
11.3 Recombinant Hormone Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT HORMONE BY GEOGRAPHIC REGION
12.1 Global Recombinant Hormone Market Size Forecast by Region
12.1.1 Global Recombinant Hormone Forecast by Region (2023-2028)
12.1.2 Global Recombinant Hormone Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Hormone Forecast by Type
12.7 Global Recombinant Hormone Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly and Company
13.1.1 Eli Lilly and Company Company Information
13.1.2 Eli Lilly and Company Recombinant Hormone Product Offered
13.1.3 Eli Lilly and Company Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly and Company Main Business Overview
13.1.5 Eli Lilly and Company Latest Developments
13.2 Ferring Pharmaceuticals
13.2.1 Ferring Pharmaceuticals Company Information
13.2.2 Ferring Pharmaceuticals Recombinant Hormone Product Offered
13.2.3 Ferring Pharmaceuticals Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Ferring Pharmaceuticals Main Business Overview
13.2.5 Ferring Pharmaceuticals Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Recombinant Hormone Product Offered
13.3.3 Merck Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Recombinant Hormone Product Offered
13.4.3 Pfizer Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Novo Nordisk
13.5.1 Novo Nordisk Company Information
13.5.2 Novo Nordisk Recombinant Hormone Product Offered
13.5.3 Novo Nordisk Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novo Nordisk Main Business Overview
13.5.5 Novo Nordisk Latest Developments
13.6 Novartis AG
13.6.1 Novartis AG Company Information
13.6.2 Novartis AG Recombinant Hormone Product Offered
13.6.3 Novartis AG Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis AG Main Business Overview
13.6.5 Novartis AG Latest Developments
13.7 Ipsen
13.7.1 Ipsen Company Information
13.7.2 Ipsen Recombinant Hormone Product Offered
13.7.3 Ipsen Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Ipsen Main Business Overview
13.7.5 Ipsen Latest Developments
13.8 LG Chem
13.8.1 LG Chem Company Information
13.8.2 LG Chem Recombinant Hormone Product Offered
13.8.3 LG Chem Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 LG Chem Main Business Overview
13.8.5 LG Chem Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Recombinant Hormone Product Offered
13.9.3 Teva Pharmaceutical Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Scripps Laboratories
13.10.1 Scripps Laboratories Company Information
13.10.2 Scripps Laboratories Recombinant Hormone Product Offered
13.10.3 Scripps Laboratories Recombinant Hormone Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Scripps Laboratories Main Business Overview
13.10.5 Scripps Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Hormone Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Recombinant Hormone Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Growth Hormone
Table 4. Major Players of Insulin
Table 5. Major Players of Follicle-stimulating Hormone
Table 6. Major Players of Others
Table 7. Global Recombinant Hormone Sales by Type (2017-2022) & (K Units)
Table 8. Global Recombinant Hormone Sales Market Share by Type (2017-2022)
Table 9. Global Recombinant Hormone Revenue by Type (2017-2022) & ($ million)
Table 10. Global Recombinant Hormone Revenue Market Share by Type (2017-2022)
Table 11. Global Recombinant Hormone Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Recombinant Hormone Sales by Application (2017-2022) & (K Units)
Table 13. Global Recombinant Hormone Sales Market Share by Application (2017-2022)
Table 14. Global Recombinant Hormone Revenue by Application (2017-2022)
Table 15. Global Recombinant Hormone Revenue Market Share by Application (2017-2022)
Table 16. Global Recombinant Hormone Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Recombinant Hormone Sales by Company (2020-2022) & (K Units)
Table 18. Global Recombinant Hormone Sales Market Share by Company (2020-2022)
Table 19. Global Recombinant Hormone Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Recombinant Hormone Revenue Market Share by Company (2020-2022)
Table 21. Global Recombinant Hormone Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Recombinant Hormone Producing Area Distribution and Sales Area
Table 23. Players Recombinant Hormone Products Offered
Table 24. Recombinant Hormone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Recombinant Hormone Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Recombinant Hormone Sales Market Share Geographic Region (2017-2022)
Table 29. Global Recombinant Hormone Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Recombinant Hormone Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Recombinant Hormone Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Recombinant Hormone Sales Market Share by Country/Region (2017-2022)
Table 33. Global Recombinant Hormone Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Recombinant Hormone Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Recombinant Hormone Sales by Country (2017-2022) & (K Units)
Table 36. Americas Recombinant Hormone Sales Market Share by Country (2017-2022)
Table 37. Americas Recombinant Hormone Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Recombinant Hormone Revenue Market Share by Country (2017-2022)
Table 39. Americas Recombinant Hormone Sales by Type (2017-2022) & (K Units)
Table 40. Americas Recombinant Hormone Sales Market Share by Type (2017-2022)
Table 41. Americas Recombinant Hormone Sales by Application (2017-2022) & (K Units)
Table 42. Americas Recombinant Hormone Sales Market Share by Application (2017-2022)
Table 43. APAC Recombinant Hormone Sales by Region (2017-2022) & (K Units)
Table 44. APAC Recombinant Hormone Sales Market Share by Region (2017-2022)
Table 45. APAC Recombinant Hormone Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Recombinant Hormone Revenue Market Share by Region (2017-2022)
Table 47. APAC Recombinant Hormone Sales by Type (2017-2022) & (K Units)
Table 48. APAC Recombinant Hormone Sales Market Share by Type (2017-2022)
Table 49. APAC Recombinant Hormone Sales by Application (2017-2022) & (K Units)
Table 50. APAC Recombinant Hormone Sales Market Share by Application (2017-2022)
Table 51. Europe Recombinant Hormone Sales by Country (2017-2022) & (K Units)
Table 52. Europe Recombinant Hormone Sales Market Share by Country (2017-2022)
Table 53. Europe Recombinant Hormone Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Recombinant Hormone Revenue Market Share by Country (2017-2022)
Table 55. Europe Recombinant Hormone Sales by Type (2017-2022) & (K Units)
Table 56. Europe Recombinant Hormone Sales Market Share by Type (2017-2022)
Table 57. Europe Recombinant Hormone Sales by Application (2017-2022) & (K Units)
Table 58. Europe Recombinant Hormone Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Recombinant Hormone Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Recombinant Hormone Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Recombinant Hormone Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Recombinant Hormone Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Recombinant Hormone Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Recombinant Hormone Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Recombinant Hormone Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Recombinant Hormone Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Recombinant Hormone
Table 68. Key Market Challenges & Risks of Recombinant Hormone
Table 69. Key Industry Trends of Recombinant Hormone
Table 70. Recombinant Hormone Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Recombinant Hormone Distributors List
Table 73. Recombinant Hormone Customer List
Table 74. Global Recombinant Hormone Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Recombinant Hormone Sales Market Forecast by Region
Table 76. Global Recombinant Hormone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Recombinant Hormone Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Recombinant Hormone Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Recombinant Hormone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Recombinant Hormone Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Recombinant Hormone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Recombinant Hormone Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Recombinant Hormone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Recombinant Hormone Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Recombinant Hormone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Recombinant Hormone Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Recombinant Hormone Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Recombinant Hormone Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Recombinant Hormone Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Recombinant Hormone Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Recombinant Hormone Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Recombinant Hormone Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Recombinant Hormone Revenue Market Share Forecast by Application (2023-2028)
Table 94. Eli Lilly and Company Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 95. Eli Lilly and Company Recombinant Hormone Product Offered
Table 96. Eli Lilly and Company Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Eli Lilly and Company Main Business
Table 98. Eli Lilly and Company Latest Developments
Table 99. Ferring Pharmaceuticals Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 100. Ferring Pharmaceuticals Recombinant Hormone Product Offered
Table 101. Ferring Pharmaceuticals Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Ferring Pharmaceuticals Main Business
Table 103. Ferring Pharmaceuticals Latest Developments
Table 104. Merck Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Recombinant Hormone Product Offered
Table 106. Merck Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Pfizer Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Recombinant Hormone Product Offered
Table 111. Pfizer Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. Novo Nordisk Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 115. Novo Nordisk Recombinant Hormone Product Offered
Table 116. Novo Nordisk Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Novo Nordisk Main Business
Table 118. Novo Nordisk Latest Developments
Table 119. Novartis AG Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis AG Recombinant Hormone Product Offered
Table 121. Novartis AG Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Novartis AG Main Business
Table 123. Novartis AG Latest Developments
Table 124. Ipsen Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 125. Ipsen Recombinant Hormone Product Offered
Table 126. Ipsen Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Ipsen Main Business
Table 128. Ipsen Latest Developments
Table 129. LG Chem Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 130. LG Chem Recombinant Hormone Product Offered
Table 131. LG Chem Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. LG Chem Main Business
Table 133. LG Chem Latest Developments
Table 134. Teva Pharmaceutical Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 135. Teva Pharmaceutical Recombinant Hormone Product Offered
Table 136. Teva Pharmaceutical Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Teva Pharmaceutical Main Business
Table 138. Teva Pharmaceutical Latest Developments
Table 139. Scripps Laboratories Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 140. Scripps Laboratories Recombinant Hormone Product Offered
Table 141. Scripps Laboratories Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Scripps Laboratories Main Business
Table 143. Scripps Laboratories Latest Developments
Table 1. Recombinant Hormone Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Recombinant Hormone Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Growth Hormone
Table 4. Major Players of Insulin
Table 5. Major Players of Follicle-stimulating Hormone
Table 6. Major Players of Others
Table 7. Global Recombinant Hormone Sales by Type (2017-2022) & (K Units)
Table 8. Global Recombinant Hormone Sales Market Share by Type (2017-2022)
Table 9. Global Recombinant Hormone Revenue by Type (2017-2022) & ($ million)
Table 10. Global Recombinant Hormone Revenue Market Share by Type (2017-2022)
Table 11. Global Recombinant Hormone Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Recombinant Hormone Sales by Application (2017-2022) & (K Units)
Table 13. Global Recombinant Hormone Sales Market Share by Application (2017-2022)
Table 14. Global Recombinant Hormone Revenue by Application (2017-2022)
Table 15. Global Recombinant Hormone Revenue Market Share by Application (2017-2022)
Table 16. Global Recombinant Hormone Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Recombinant Hormone Sales by Company (2020-2022) & (K Units)
Table 18. Global Recombinant Hormone Sales Market Share by Company (2020-2022)
Table 19. Global Recombinant Hormone Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Recombinant Hormone Revenue Market Share by Company (2020-2022)
Table 21. Global Recombinant Hormone Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Recombinant Hormone Producing Area Distribution and Sales Area
Table 23. Players Recombinant Hormone Products Offered
Table 24. Recombinant Hormone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Recombinant Hormone Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Recombinant Hormone Sales Market Share Geographic Region (2017-2022)
Table 29. Global Recombinant Hormone Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Recombinant Hormone Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Recombinant Hormone Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Recombinant Hormone Sales Market Share by Country/Region (2017-2022)
Table 33. Global Recombinant Hormone Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Recombinant Hormone Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Recombinant Hormone Sales by Country (2017-2022) & (K Units)
Table 36. Americas Recombinant Hormone Sales Market Share by Country (2017-2022)
Table 37. Americas Recombinant Hormone Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Recombinant Hormone Revenue Market Share by Country (2017-2022)
Table 39. Americas Recombinant Hormone Sales by Type (2017-2022) & (K Units)
Table 40. Americas Recombinant Hormone Sales Market Share by Type (2017-2022)
Table 41. Americas Recombinant Hormone Sales by Application (2017-2022) & (K Units)
Table 42. Americas Recombinant Hormone Sales Market Share by Application (2017-2022)
Table 43. APAC Recombinant Hormone Sales by Region (2017-2022) & (K Units)
Table 44. APAC Recombinant Hormone Sales Market Share by Region (2017-2022)
Table 45. APAC Recombinant Hormone Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Recombinant Hormone Revenue Market Share by Region (2017-2022)
Table 47. APAC Recombinant Hormone Sales by Type (2017-2022) & (K Units)
Table 48. APAC Recombinant Hormone Sales Market Share by Type (2017-2022)
Table 49. APAC Recombinant Hormone Sales by Application (2017-2022) & (K Units)
Table 50. APAC Recombinant Hormone Sales Market Share by Application (2017-2022)
Table 51. Europe Recombinant Hormone Sales by Country (2017-2022) & (K Units)
Table 52. Europe Recombinant Hormone Sales Market Share by Country (2017-2022)
Table 53. Europe Recombinant Hormone Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Recombinant Hormone Revenue Market Share by Country (2017-2022)
Table 55. Europe Recombinant Hormone Sales by Type (2017-2022) & (K Units)
Table 56. Europe Recombinant Hormone Sales Market Share by Type (2017-2022)
Table 57. Europe Recombinant Hormone Sales by Application (2017-2022) & (K Units)
Table 58. Europe Recombinant Hormone Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Recombinant Hormone Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Recombinant Hormone Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Recombinant Hormone Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Recombinant Hormone Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Recombinant Hormone Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Recombinant Hormone Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Recombinant Hormone Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Recombinant Hormone Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Recombinant Hormone
Table 68. Key Market Challenges & Risks of Recombinant Hormone
Table 69. Key Industry Trends of Recombinant Hormone
Table 70. Recombinant Hormone Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Recombinant Hormone Distributors List
Table 73. Recombinant Hormone Customer List
Table 74. Global Recombinant Hormone Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Recombinant Hormone Sales Market Forecast by Region
Table 76. Global Recombinant Hormone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Recombinant Hormone Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Recombinant Hormone Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Recombinant Hormone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Recombinant Hormone Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Recombinant Hormone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Recombinant Hormone Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Recombinant Hormone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Recombinant Hormone Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Recombinant Hormone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Recombinant Hormone Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Recombinant Hormone Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Recombinant Hormone Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Recombinant Hormone Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Recombinant Hormone Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Recombinant Hormone Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Recombinant Hormone Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Recombinant Hormone Revenue Market Share Forecast by Application (2023-2028)
Table 94. Eli Lilly and Company Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 95. Eli Lilly and Company Recombinant Hormone Product Offered
Table 96. Eli Lilly and Company Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Eli Lilly and Company Main Business
Table 98. Eli Lilly and Company Latest Developments
Table 99. Ferring Pharmaceuticals Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 100. Ferring Pharmaceuticals Recombinant Hormone Product Offered
Table 101. Ferring Pharmaceuticals Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Ferring Pharmaceuticals Main Business
Table 103. Ferring Pharmaceuticals Latest Developments
Table 104. Merck Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Recombinant Hormone Product Offered
Table 106. Merck Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Pfizer Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Recombinant Hormone Product Offered
Table 111. Pfizer Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. Novo Nordisk Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 115. Novo Nordisk Recombinant Hormone Product Offered
Table 116. Novo Nordisk Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Novo Nordisk Main Business
Table 118. Novo Nordisk Latest Developments
Table 119. Novartis AG Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis AG Recombinant Hormone Product Offered
Table 121. Novartis AG Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Novartis AG Main Business
Table 123. Novartis AG Latest Developments
Table 124. Ipsen Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 125. Ipsen Recombinant Hormone Product Offered
Table 126. Ipsen Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Ipsen Main Business
Table 128. Ipsen Latest Developments
Table 129. LG Chem Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 130. LG Chem Recombinant Hormone Product Offered
Table 131. LG Chem Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. LG Chem Main Business
Table 133. LG Chem Latest Developments
Table 134. Teva Pharmaceutical Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 135. Teva Pharmaceutical Recombinant Hormone Product Offered
Table 136. Teva Pharmaceutical Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Teva Pharmaceutical Main Business
Table 138. Teva Pharmaceutical Latest Developments
Table 139. Scripps Laboratories Basic Information, Recombinant Hormone Manufacturing Base, Sales Area and Its Competitors
Table 140. Scripps Laboratories Recombinant Hormone Product Offered
Table 141. Scripps Laboratories Recombinant Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Scripps Laboratories Main Business
Table 143. Scripps Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant Hormone
Figure 2. Recombinant Hormone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Hormone Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Recombinant Hormone Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Recombinant Hormone Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Growth Hormone
Figure 10. Product Picture of Insulin
Figure 11. Product Picture of Follicle-stimulating Hormone
Figure 12. Product Picture of Others
Figure 13. Global Recombinant Hormone Sales Market Share by Type in 2021
Figure 14. Global Recombinant Hormone Revenue Market Share by Type (2017-2022)
Figure 15. Recombinant Hormone Consumed in Hospital
Figure 16. Global Recombinant Hormone Market: Hospital (2017-2022) & (K Units)
Figure 17. Recombinant Hormone Consumed in Clinic
Figure 18. Global Recombinant Hormone Market: Clinic (2017-2022) & (K Units)
Figure 19. Recombinant Hormone Consumed in Others
Figure 20. Global Recombinant Hormone Market: Others (2017-2022) & (K Units)
Figure 21. Global Recombinant Hormone Sales Market Share by Application (2017-2022)
Figure 22. Global Recombinant Hormone Revenue Market Share by Application in 2021
Figure 23. Recombinant Hormone Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Recombinant Hormone Revenue Market Share by Company in 2021
Figure 25. Global Recombinant Hormone Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Recombinant Hormone Revenue Market Share by Geographic Region in 2021
Figure 27. Global Recombinant Hormone Sales Market Share by Region (2017-2022)
Figure 28. Global Recombinant Hormone Revenue Market Share by Country/Region in 2021
Figure 29. Americas Recombinant Hormone Sales 2017-2022 (K Units)
Figure 30. Americas Recombinant Hormone Revenue 2017-2022 ($ Millions)
Figure 31. APAC Recombinant Hormone Sales 2017-2022 (K Units)
Figure 32. APAC Recombinant Hormone Revenue 2017-2022 ($ Millions)
Figure 33. Europe Recombinant Hormone Sales 2017-2022 (K Units)
Figure 34. Europe Recombinant Hormone Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Recombinant Hormone Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Recombinant Hormone Revenue 2017-2022 ($ Millions)
Figure 37. Americas Recombinant Hormone Sales Market Share by Country in 2021
Figure 38. Americas Recombinant Hormone Revenue Market Share by Country in 2021
Figure 39. United States Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Recombinant Hormone Sales Market Share by Region in 2021
Figure 44. APAC Recombinant Hormone Revenue Market Share by Regions in 2021
Figure 45. China Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Recombinant Hormone Sales Market Share by Country in 2021
Figure 52. Europe Recombinant Hormone Revenue Market Share by Country in 2021
Figure 53. Germany Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Recombinant Hormone Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Recombinant Hormone Revenue Market Share by Country in 2021
Figure 60. Egypt Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Recombinant Hormone in 2021
Figure 66. Manufacturing Process Analysis of Recombinant Hormone
Figure 67. Industry Chain Structure of Recombinant Hormone
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 1. Picture of Recombinant Hormone
Figure 2. Recombinant Hormone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Hormone Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Recombinant Hormone Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Recombinant Hormone Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Growth Hormone
Figure 10. Product Picture of Insulin
Figure 11. Product Picture of Follicle-stimulating Hormone
Figure 12. Product Picture of Others
Figure 13. Global Recombinant Hormone Sales Market Share by Type in 2021
Figure 14. Global Recombinant Hormone Revenue Market Share by Type (2017-2022)
Figure 15. Recombinant Hormone Consumed in Hospital
Figure 16. Global Recombinant Hormone Market: Hospital (2017-2022) & (K Units)
Figure 17. Recombinant Hormone Consumed in Clinic
Figure 18. Global Recombinant Hormone Market: Clinic (2017-2022) & (K Units)
Figure 19. Recombinant Hormone Consumed in Others
Figure 20. Global Recombinant Hormone Market: Others (2017-2022) & (K Units)
Figure 21. Global Recombinant Hormone Sales Market Share by Application (2017-2022)
Figure 22. Global Recombinant Hormone Revenue Market Share by Application in 2021
Figure 23. Recombinant Hormone Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Recombinant Hormone Revenue Market Share by Company in 2021
Figure 25. Global Recombinant Hormone Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Recombinant Hormone Revenue Market Share by Geographic Region in 2021
Figure 27. Global Recombinant Hormone Sales Market Share by Region (2017-2022)
Figure 28. Global Recombinant Hormone Revenue Market Share by Country/Region in 2021
Figure 29. Americas Recombinant Hormone Sales 2017-2022 (K Units)
Figure 30. Americas Recombinant Hormone Revenue 2017-2022 ($ Millions)
Figure 31. APAC Recombinant Hormone Sales 2017-2022 (K Units)
Figure 32. APAC Recombinant Hormone Revenue 2017-2022 ($ Millions)
Figure 33. Europe Recombinant Hormone Sales 2017-2022 (K Units)
Figure 34. Europe Recombinant Hormone Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Recombinant Hormone Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Recombinant Hormone Revenue 2017-2022 ($ Millions)
Figure 37. Americas Recombinant Hormone Sales Market Share by Country in 2021
Figure 38. Americas Recombinant Hormone Revenue Market Share by Country in 2021
Figure 39. United States Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Recombinant Hormone Sales Market Share by Region in 2021
Figure 44. APAC Recombinant Hormone Revenue Market Share by Regions in 2021
Figure 45. China Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Recombinant Hormone Sales Market Share by Country in 2021
Figure 52. Europe Recombinant Hormone Revenue Market Share by Country in 2021
Figure 53. Germany Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Recombinant Hormone Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Recombinant Hormone Revenue Market Share by Country in 2021
Figure 60. Egypt Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Recombinant Hormone Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Recombinant Hormone in 2021
Figure 66. Manufacturing Process Analysis of Recombinant Hormone
Figure 67. Industry Chain Structure of Recombinant Hormone
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
